
UCLH Opens Europe’s First CAR T Trial for Rare Amyloidosis Patients
UCLH has launched Europe’s first CAR T trial for rare amyloidosis, testing a new option for a serious blood disease.
Health news on a wide range of other conditions, from rare diseases to newly recognised health risks.

UCLH has launched Europe’s first CAR T trial for rare amyloidosis, testing a new option for a serious blood disease.

NICE has opened routine NHS access to nusinersen and risdiplam for eligible patients with spinal muscular atrophy in England.

NICE has approved givinostat for Duchenne muscular dystrophy, expanding NHS access for around 530 people in England.

NICE recommends rozanolixizumab, the first treatment for uncontrolled generalised myasthenia gravis on the NHS in England.

NHS England reports record A&E demand in March as a meningitis outbreak adds pressure to hospitals across the health system.

NHS data shows pandemic-era diagnosis gaps for depression, asthma and COPD persist in England.

NICE has published its first rare disease quality standard, aiming to improve diagnosis, treatment and support across the NHS.

Climate change is expanding the range and seasonality of ticks across Europe, increasing cases of Lyme disease and tick‑borne encephalitis and prompting public health responses.